Identification of a novel ALK inhibitor-sensitive PRKCE-ALK gene fusion in lung adenocarcinoma

MeSH terms

• Adenocarcinoma of Lung* / drug therapy
• Adenocarcinoma of Lung* / genetics
• Adenocarcinoma of Lung* / pathology
• Adenocarcinoma* / drug therapy
• Adenocarcinoma* / genetics
• Adenocarcinoma* / pathology
• Anaplastic Lymphoma Kinase* / antagonists & inhibitors
• Anaplastic Lymphoma Kinase* / genetics
• Crizotinib / pharmacology
• Crizotinib / therapeutic use
• Female
• Humans
• Lung Neoplasms* / drug therapy
• Lung Neoplasms* / genetics
• Lung Neoplasms* / pathology
• Male
• Middle Aged
• Oncogene Proteins, Fusion* / genetics
• Protein Kinase Inhibitors* / pharmacology
• Protein Kinase Inhibitors* / therapeutic use
• Receptor Protein-Tyrosine Kinases / genetics